Materials and Methods

Prediction
single attribute, the RFDT algorithm performed the best and was given the highest weight in the classification of uncharacterized proteins. The RFDT algorithm, founded on the method presented by Breiman (3) , is based on a collection (or forest) of individual decision trees. The classifier was provided with training and test datasets comprised of "known secreted" and "known non-secreted". These datasets consisted of representative mammalian secreted proteins, extracellular exposed regions of transmembrane proteins, cytoplasmic proteins and the cytoplasmic exposed regions of transmembrane proteins. For each protein, 75 numerical attributes were generated:
These attributes were based on physical and chemical properties of the amino acid sequences and were supplied to the RFDT for classification. A given decision tree was constructed by recursively splitting the training data on randomly chosen hyperplanes in the N-dimensional attribute space. Along a branch, the splitting continues until there is a single protein whence the branch terminates in a leaf, which is classified as secreted or non-secreted according to the single protein in the leaf. Thus the tree is defined by the randomly chosen hyperplanes and the secreted categories of the leaves. The algorithm then classifies a new protein by sending it to a leaf and assigning the same category as the leaf. Because any single decision tree provides a perfect classification of the training data, noise in the data is also present in each tree. By combining the predictions of all the trees in the forest into a collective prediction, known as a tree-vote, the noise is averaged which increases the predictive accuracy of the forest level. Accuracy can be improved by increasing the number of trees in the forest.
Compilation of the secreted protein cDNA collection. cDNAs for secreted and membrane proteins were prepared by first generating large numbers of full-length cDNA clones (4) from a wide diversity of human tissues (table S1). End sequences from about 300,000 full-length clones were experimentally determined and the clones were clustered to approximately 19, 000 loci (table S3) . The specific cDNAs encoding secreted and extracellular transmembrane proteins to be used in the functional assays were selected from this clone collection (table S3) using algorithms described above. A total of 2200 secreted proteins, 1100 Type I surface single transmembrane proteins, 480 type II surface single transmembrane proteins and 400 multi-spanning non-olfactory extracellular transmembrane proteins with long (greater than 20 amino acids) extracellular N-termini were compiled (table S2) .
The cDNA collection used in functional screening consists of 91% of the secreted protein genes, 74% of the type I surface single transmembrane protein genes, 90% of the type II surface single transmembrane protein genes, and 57% of the surface multiple transmembrane protein genes (MTMs; excluding the predicted olfactory receptors) (table S2) . Each cDNA in the collection of secreted proteins was fully sequenced and curated individually. The membrane protein collection was created in the same manner except that the cDNAs were truncated so that only extracellular domains (ECDs) were produced. The truncations were made at the boundary between the extracellular region and the transmembrane sequence or a known or predicted shed site located in the juxtamembrane region. The signal peptide sequence from human collagen, type IX, alpha 1, found to be a highly expressed protein in our system, was engineered into the N-terminus of the ECD of the type II surface single transmembrane protein cDNAs to direct them to the secretory pathway. Tagged (C-terminal V5-His tag) and untagged versions of each cDNA were sub-cloned into the pTT5 expression vector (from National Research Council Canada) (5) and expressed in parallel. The tagged versions were used to assess expression using epitope tag detection methods and the untagged versions were used in functional screens. More than 90% of the tagged proteins were detected in the culture supernatant of the 293T cells. Human hematopoietic colony formation assay. Colony formation assays were performed by StemCell Technologies Inc. as described (7) The total cell lysate containing equal amount (10 μg) of protein was analyzed in a 10%
Bis-Tris NuPAGE reducing gel (Invitrogen) followed by Western blotting using an antibody to phospho-ERK1/2 (p-ERK) (Santa Cruz Biotechnology, Inc., no. sc-7383).
The Western blot was then stripped and re-probed with antibodies to ERK (Santa Cruz Biotechnology, Inc., no. sc-94) for detection of the total ERK.
Supplemental Figures and Legends fig. S1. Expression analysis of a set of tagged secreted proteins. (A)
Conditioned media from 293T cells transfected with a random set of 160 cDNAs encoding V5-Histagged proteins were subjected to Western blot analysis detected with an anti-V5 antibody-HRP (Invitrogen). Molecular weight markers and gel lanes are indicated for each protein gel. (B) Protein expression levels for 2068 V5-His-tagged proteins in the conditioned media from 293T cells transfected with secreted protein clones were determined by a sandwich ELISA assay using anti-His tag antibody as a capture antibody and anti-V5 antibody-HRP as a detection antibody. Expression levels were measured relative to a standard curve of purified IL-1 receptor antagonist-V5-HIS with a detection limit of 10 ng/ml and a detection range from 2 to 1250 ng/ml. Over 90% of the proteins were detected in the culture supernatant with a mean expression level of 75 ng/ml and a median of 20 ng/ml.
fig. S2. Selectivity of proteins is independent of protein expression levels. (A)
Activity from screening assays ( fig. S2A and fig. S2B verified that there is no statistically significant dependence of activity or maximal differential activity on protein concentration (table S7 and table S8 , respectively). fig. S3 . Activity of the secreted protein set in a high-throughput monocyte viability screening assay. The entire set of cDNAs predicted to encode secreted proteins and extracellular domains (ECDs) of transmembrane proteins were sub-cloned into the pTT5 expression vector (5) and individually transfected into 293T cells. Unactivated human primary monocytes were purified (6) and treated for four days with conditioned media of the transfected 293T cells in 96-well plates and monocyte viability was determined by a cell viability (CellTiter-Glo) luminescence assay (Promega). Primary screening data are represented as standard deviation from median (sigma from median) of each assay plate. Two or more assay data points for each clone are shown. Green (activators) and purple circles (inhibitors) indicate clones for which activity was detected with greater than 2.5-fold standard deviation of the assay plate for more than one test. Red circles indicate values for IL-34. Conditioned medium of 293T cells transfected with GM-CSF cDNA was used as a positive control (blue crosses) on each assay plate. A list of clones that hit in the primary monocyte viability screen and were confirmed to stimulate monocyte viability in secondary assays is shown in table S5. fig. S4 . Alignment of human, chimpanzee, rat, and mouse IL-34 amino acid sequences. Polypeptide sequences of human IL-34, isoform 1 (GenBank accession number EU599219), chimpanzee IL-34, isoform 1, rat IL-34, isoform 1 (GenBank accession number AAH98808), and mouse IL-34, isoform 1 (GenBank accession number EU636995) are compared. Human hypothetical protein LOC146433 (GenBank accession number NP_689669), designated as IL-34, isoform 2 (GenBank accession number EU636994), has one additional amino acid (glutamine) between amino acid residues 80 and 81 in the IL-34, isoform 1 sequence, which is likely generated by alternative mRNA splicing. Chimpanzee IL-34, isoform 1 was predicted from genomic sequence and chimpanzee IL-34, isoform 2 is identical to chimpanzee hypothetical protein, isoform 2 (GenBank accession number XP_511082). The mouse IL-34, isoform 2 sequence (GenBank accession number EU636996) is identical to 2010004A03Rik protein (GenBank accession number AAH16254). The signal peptide (amino acid residues 1 to 20) in the human IL-34 sequence is indicated by a line on top of the sequence. * Data from these assays were combined in calculation for function selectivity.
** Proteins active in this assay were tested for muscle cell glucose uptake in vitro.
*** Data from these assays were combined in calculation for function selectivity. * Note: There was no positive association (P value = 0.323) nor negative association (P value = 0.749) between protein concentration and maximal differential activity.
